Prot #RPC02-201: A Phase 2, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects with Eosinophilic Esophagitis

Project: Research project

Project Details

StatusFinished
Effective start/end date9/22/143/31/19

Funding

  • Agility Clinical (Prot #RPC02-201)
  • Receptos, Inc. (Prot #RPC02-201)